Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Postgastrectomy Syndromes 1Metabolic Syndrome 1Metabolic Diseases 1Insulin Resistance 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Gastric Bypass × Clear all
NCT01714622 2019-03-29

Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance

Yonsei University

Withdrawn
Gastrointestinal

Insulin Resistance, Metabolic Diseases, Stomach Neoplasms, Metabolic Syndrome

NCT00622804 2009-08-03

Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy

The Catholic University of Korea

Phase 3 Withdrawn
90 enrolled
Gastrointestinal

Postgastrectomy Syndromes, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡